Molecular Biosystems, Inc. (MBI), founded in 1980, is a biomedical company developing a range of contrast agents for use with diagnostic ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT).
Alliance Pharmaceutical Corp. acquires Molecular Biosystems in Nov. 2000.

Non-linear imaging is used to detect primary non-linear components of the received echo. Non-linear methods like harmonic imaging and pulse inversion imaging are designed to detect ultrasound contrast agents.

See also Contrast Pulse Sequencing, and Power Modulation.

The persistence of microbubbles is depended of the shell stability and the density of the gas.
This is defined by the equation:
(R x d)/(DIFS x const_sat)
where R is the bubble radius, d the gas density, DIFS the gas diffusivity and const_sat the saturation constant.
Microbubbles are stabilized with thin coatings of substances such as palmitic acid or by encapsulation in microspheres made with albumin, lipids, or polymers. Low-solubility low-diffusibility gases dramatically improve the persistence. Most recently developed ultrasound contrast agents combine these two approaches to prolong contrast enhancement.
Persistence is also a type of temporal smoothing used in both gray scale and color Doppler imaging. Successive frames are averaged as they are displayed to reduce the variations in the image between frames, hence lowering the temporal resolution of the image.

Different stages of testing drugs in humans for example ultrasound contrast agents, from first application in humans through limited and broad clinical tests, to postmarketing studies. Preclinical trials are the testing in animals.

See also Drug Development and Approval Process USA, Food and Drug Administration, and European Medicines Agency.

Phospholipids are a major component of all biological membranes. When placed in water, phospholipids form a bilayer, where the hydrophobic tails line up against each other. This forms a membrane with hydrophilic heads on both sides. This membrane is partially permeable and very flexible.
Phospholipid containing microbubbles are in use as diagnostic ultrasound contrast agents. Phospholipids can be targeted to atheroma and other pathologic components to enhance atherosclerosis imaging. The majority of these echogenic liposomes range in diameter from 0.25 to 5.0 μm.